艾迪注射液与TCF联合对胃癌患者化疗反应及生存质量的影响

Effects of Addie injection and TCF combined chemotherapy on response to chemotherapy and quality of life of patients with gastric cancer

目的探讨艾迪注射液与TCF化疗联合干预对胃癌患者化疗反应及生存质量的影响。方法纳入胃癌患者76例,随机分为观察组和对照组各38例,观察组给予TCF方案即艾迪注射液联合紫杉醇(TAX)+亚叶酸钙(CF)+5-氟尿嘧啶(5-Fu)治疗,对照组给予单纯TCF化疗干预,治疗周期均为4周。检测两组胃癌患者不同治疗方案临床疗效以及治疗后不良反应发生情况,并采用EORT-CQLQ-C30评分量表评估两组生存质量包括躯体功能、角色功能、认知功能、情绪功能和社会功能5个功能。结果观察组、对照组总有效率分别为81.58%、60.52%,差异有统计学意义(P<0.05)。观察组不良反应发生率为7.89%,显著低于对照组的26.32%(P<0.05)。治疗前两组生存质量各项评分比较差异无统计学意义(P>0.05);观察组治疗后躯体功能、角色功能、认知功能、情绪功能和社会功能评分分别为(89.55±11.11)、(70.88±13.66)、(74.54±11.20)、(70.99±13.02)、(70.98±14.96)分,均显著高于对照组(P<0.05)。结论艾迪注射液与TCF化疗联合干预治疗胃癌患者临床疗效显著,艾迪注射液能显著降低毒性,安全性高,并能有效提高患者生存质量。

Objective To explore the effects of Addie injection and TCF combined chemotherapy on response to chemotherapy and quality of life of patients with gastric cancer. Methods A total of 76 patients with gastric cancer were randomly divided into the observation group and the control group, 38 cases in each group. The observation group were treated with Addie injection combined with taxol(TAX),calcium folinate(CF) and 5-fluorouracil(5-Fu), while the control group were treated with TCF chemotherapy alone. The clinical curative effects of different treatment regimens in two groups and occurrence of adverse reactions after treatment were observed. The quality of life of the two groups, including physical function, role function, cognitive function, emotional function and social function were analyzed. Results The total effective rates in the observation group and the control group were 81.58% and 60.52% respectively and the difference was significant(P<0.05). The incidence of adverse reactions in the observation group(7.89%) was significantly lower than that in the control group(26.32%)(P < 0.05). There was no significant difference in the 5 quality of life between the two groups before treatment(P>0.05). After treatment, scores of the 5 quality of life indexes in the observation group [(89.55±11.11),(70.88±13.66),(74.54±11.20),(7.099±13.02),(70.98±14.96)] were significantly higher than those in the control group(all P<0.05). Conclusions Combined chemotherapy of Aidi injection and TCF has significant clinical curative effect in the treatment of patients with gastric cancer. Aidi injection can significantly reduce toxicity, has high safety and improve the quality of life of patients.